Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - Revolution Medicines, Inc. | rvmd-ex322_7.htm |
EX-32.1 - EX-32.1 - Revolution Medicines, Inc. | rvmd-ex321_6.htm |
EX-31.2 - EX-31.2 - Revolution Medicines, Inc. | rvmd-ex312_9.htm |
EX-31.1 - EX-31.1 - Revolution Medicines, Inc. | rvmd-ex311_8.htm |
EX-4.3 - EX-4.3 - Revolution Medicines, Inc. | rvmd-ex43_1211.htm |
10-K - 10-K - Revolution Medicines, Inc. | rvmd-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-236493) of Revolution Medicines, Inc. of our report dated March 30, 2020 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 30, 2020